Science

Feb 13, 2025, 17:00

Myeloma Paper of the Day, February 12th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: CAR+ T-cell lymphoma after cilta-cel therapy for relapsed or refractory myeloma that developed in two patients treated on the phase 3 CARTITUDE-4 trial who had evidence of detectable CAR transgene expression and integration.”

“CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma”

Authors: Simon Harrison, Cyrille Touzeau, Nicolas Kint, Benoit Tessoulin, Piers Blombery et al.

More posts featuring Robert Orlowski.

Benoit Tessoulin cancer CAR+ T-cell lymphoma CARTITUDE-4 Cilta-cel Therapy Cyrille Touzeau Myeloma Paper of the Day Nicolas Kint OncoDaily Oncology Piers Blombery refractory myeloma relapsed myeloma Robert Orlowski Simon Harrison

ACT for Children: Tackling Inequities in Childhood Cancer Through Unique Global Collaboration

Richard Gere and Alejandra Gere to Join Second Global OncoThon on February 15 for Fight Against Childhood Cancer

Mesothelioma Guideline Updates from ASCO 2024: Key Advances in Diagnosis and Treatment

Oncologist Near Me - Lynn Schuchter: A Pioneering Leader in Cancer Care and Melanoma Research

HHS canceled 62 contract worth $182 million - Department of Government Efficiency